Juisci SA

Based in France, Juisci SA specializes in AI-driven solutions that enhance the accessibility and engagement of medical content for healthcare professionals. The company aims to streamline how medical literature is curated and shared. Juisci SA is a French company based in Neuilly Sur Seine that utilizes artificial intelligence to improve access to medical publications for healthcare professionals. Founded in 2021, the company has been involved in two deals.

In September 2025, Juisci SA raised EUR 5. 5 million in seed funding co-led by Big Pi Ventures and Ring Capital, with participation from Bpifrance Investissement, Colloquium, Wendel, and Super Capital VC. Juisci offers a suite of innovative products designed to enhance the accessibility and engagement of medical content for healthcare professionals. Central to its offerings is the Juisci Mobile App, which allows users to discover the latest medical publications, create and share content, and build their professional networks.

The app utilizes artificial intelligence to curate, summarize, translate, and recommend relevant medical literature, addressing challenges healthcare professionals face in staying current amidst a rapidly evolving landscape. Additionally, the Juisci Workspace serves as a customizable dashboard and app space, helping users automate research tasks and scale content generation. These products are primarily targeted at healthcare professionals, organizations, and medical practitioners in North America, Europe, and parts of Asia, providing crucial resources for accessing timely medical information. Revenue generation at Juisci is based on subscription models that allow healthcare professionals to access its products and services.

Users engage with the Juisci Mobile App and Juisci Workspace through tiered subscription plans, offering varying levels of access to curated content, publication summaries, and community engagement tools. Partnerships with healthcare organizations and educational institutions also contribute to revenue, as these entities may include Juisci's services in their professional development resources. The company emphasizes delivering value through its offerings, ensuring that users have a comprehensive experience in managing and utilizing medical content effectively. The company plans to use the funding from September 2025 to strengthen its R&D, grow its team, expand internationally, especially in the US market, and accelerate the development of its AI software suite.